However, the clinical response of CRC to anti-EGFR Abs is poor for tumors with the Kirsten rat sarcoma viral oncogene homolog (Kras) mutation mostly at codons 12, 13, or 61 [7,8], which are found in 40% of metastatic CRCs. The gene discussed is KRAS; the disease is colorectal carcinoma.